RE: Ok let me get this straight20 Dec 2021 14:08
New ordinary shares were priced at 11p, an impressive 80% premium on the closing share price on Friday.
Many of the issued shares were bought by Lanstead Capital, who acquired 20mln, with the funds raised to be provided incrementally over the next two years.
Alora Pharmaceuticals LLC, the parent company of Avion Pharmaceuticals, also bought roughly 10mln with the remaining being acquired by a ‘long-standing institutional investor.’
ImmuPharma has a licensing agreement with Avion Pharmaceuticals, with this investment further strengthening the partnership between the two.
Shares are trading at a discounted price to the subscription, however expect some larger buyers to fill sub subscription price.